GAM Holding AG - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 144 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.48 and the average weighting 0.7%.

Quarter-by-quarter ownership
GAM Holding AG ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$544,000
-28.0%
10,527
-51.3%
0.02%
-45.7%
Q3 2020$756,000
-34.5%
21,6000.0%0.05%
-36.1%
Q2 2020$1,155,000
+50.8%
21,6000.0%0.07%
+38.5%
Q1 2020$766,000
-25.7%
21,6000.0%0.05%
+6.1%
Q4 2019$1,031,000
+47.3%
21,6000.0%0.05%
+58.1%
Q3 2019$700,000
-35.0%
21,6000.0%0.03%
-26.2%
Q2 2019$1,077,000
-26.1%
21,6000.0%0.04%
-31.1%
Q1 2019$1,457,000
+46.3%
21,6000.0%0.06%
+22.0%
Q4 2018$996,000
-46.6%
21,600
-10.7%
0.05%
-26.5%
Q3 2018$1,866,000
-8.4%
24,2000.0%0.07%
-4.2%
Q2 2018$2,038,000
+3.0%
24,2000.0%0.07%
+1.4%
Q1 2018$1,979,000
+43.0%
24,2000.0%0.07%
+66.7%
Q4 2017$1,384,000
+168.7%
24,200
+142.0%
0.04%
+425.0%
Q2 2017$515,000
+25.9%
10,000
+42.9%
0.01%
+33.3%
Q1 2017$409,000
+40.1%
7,0000.0%0.01%
+20.0%
Q4 2016$292,000
-21.1%
7,0000.0%0.01%
-28.6%
Q3 2016$370,000
-77.6%
7,000
-82.2%
0.01%
-73.1%
Q2 2016$1,651,000
+13.9%
39,400
+10.4%
0.03%
+8.3%
Q1 2016$1,449,000
-51.2%
35,700
-21.9%
0.02%
-47.8%
Q4 2015$2,967,000
+185.8%
45,700
+210.9%
0.05%
+155.6%
Q3 2015$1,038,000
+146.0%
14,700
+286.8%
0.02%
+200.0%
Q2 2015$422,0003,8000.01%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 2,661,605$61,137,0671.46%
Bellevue Group AG 4,013,500$92,190,0951.34%
Eagle Health Investments LP 267,630$6,147,4611.20%
ARMISTICE CAPITAL, LLC 3,460,000$79,476,2001.14%
Integral Health Asset Management, LLC 213,000$4,892,6100.99%
SUVRETTA CAPITAL MANAGEMENT, LLC 454,000$10,428,3800.44%
ArrowMark Colorado Holdings LLC 1,557,705$35,780,4840.41%
FARALLON CAPITAL MANAGEMENT LLC 2,092,829$48,072,2820.27%
Virtus ETF Advisers LLC 9,932$228,1380.13%
JACOBS LEVY EQUITY MANAGEMENT, INC 614,533$14,115,8230.09%
View complete list of AGIOS PHARMACEUTICALS INC shareholders